News, Resources, & Updates

All
  • All
  • Articles
  • Calendar
  • Compliance
  • Newsletter
  • Position Statements
  • Press Release
  • Regulatory
  • Uncategorized

2017 Updates in the Homeopathic Pharmacopeia

By Eric L. Foxman, R.Ph., senior scientist, HPCUS June 1, 2017 Before proceeding to review the major areas of updates in the HPUS, two specific...
Delivering key messages

Delivering Key Messages

By Alissa Gould, public relations manager, Boiron USA June 1, 2017 Building on April and May 2017 articles on preparing for important communications and developing...
Developing key messages

Developing Key Messages

By Alissa Gould, public relations manager, Boiron USA May 1, 2017 Last month (April 2017), I shared an article on being prepared and asking the...

Homeopathic Manufacturers Explore Next-Generation Quality Control

MILWAUKIE, Ore., May 4, 2017 — Member companies of the American Association of Homeopathic Pharmacists (AAHP) gathered to learn about promising new technologies recently used...

Disclaimers in Advertising and Labeling: What Do They Do? Who Does What?

By Mark Land, AAHP President The FTC has long recognized that marketing claims may include additional explanatory information to prevent the claims from being misleading....

United States Food and Drug Administration Office of Pharmaceutical Quality

By Mark Land, AAHP President May 1, 2017 The Office of Pharmaceutical Quality (OPQ), created in Jan. 2015, enhances the U.S. Food and Drug Administration...

AAHP Recognized as Voice of Homeopathy on Capitol Hill

MILWAUKIE, Ore., Apr. 10, 2017 — The American Association of Homeopathic Pharmacists’ (AAHP) Legal & Regulatory Committee recently received the 2017 Henry N. Williams Professional...
Be prepared

Be Prepared: Media Basics for the Non-PR Expert

By Alissa Gould, public relations manager, Boiron USA April 1, 2017 As more people discover the benefits of homeopathic medicines, our industry may become a...

FDA Office of Surveillance and Epidemiology

By Mark Land, AAHP President April 1, 2017 FDA’s Office of Surveillance and Epidemiology (OSE) is positioned within the Center for Drug Evaluation and Research...